Metastatic Colorectal Cancer: Integrating Recent Advances Into Clinical Practice

Get up to date on the latest developments in clinical management of metastatic colorectal cancer with this comprehensive program, which features a newly updated Interactive Decision Support Tool, a downloadable PowerPoint slideset, and expert-authored commentaries.
Tanios Bekaii-Saab
Tanios Bekaii-Saab, MD, FACP
Scott Kopetz, MD, PhD, FACP
John L. Marshall, MD


At the 2019 Gastrointestinal Cancers Symposium, important new clinical data were presented on molecular testing, novel immunotherapy strategies, short-course radiation, and low-dose regorafenib in colorectal cancer.

John L. Marshall, MD Released: February 7, 2019

Many of our patients with metastatic CRC can now plan on receiving 3 or more lines of therapy. Read how I approach sequencing and dosing with regorafenib and TAS-102 in my practice.

Tanios Bekaii-Saab Tanios Bekaii-Saab, MD, FACP Released: April 24, 2019

In this commentary, I provide my thoughts on the management of select patient cases and examine treatment choices made for these cases by 5 experts in CCO’s Interactive Decision Support Tool.

Scott Kopetz, MD, PhD, FACP Released: October 31, 2019
Provided by Postgraduate Institute for Medicine
PIM Logo

Postgraduate Institute for Medicine
304 Inverness Way South, Suite 100
Englewood, CO 80112

Allison Hughes, CCMEP, Program Manager
(303) 799-1930
(303) 858-8842 (Fax)

Produced in collaboration with
Grace Logo
Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Taiho Oncology Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.